Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration
Journal of Pediatric Endocrinology and Metabolism · 2024
DOI: 10.1515/jpem-2023-0481 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2024. Verfasst von Ayşenur Engin Erdal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Heredodegenerative Disorders, Nervous System. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Objectives
The fatty acid 2-hydroxylase gene (FA2H) compound heterozygous or homozygous variants that cause spastic paraplegia type 35 (SPG35) (OMIM # 612319) are autosomal recessive HSPs. FA2H gene variants in humans have been shown to be associated with not only SPG35 but also leukodystrophy and neurodegeneration with brain iron accumulation. Case presentation A patient with a spastic gait since age seven was admitted to the paediatric metabolism department. She was born to consanguineous, healthy Turkish parents and had no family history of neurological disease. She had normal developmental milestones and was able to walk at 11 months. At age seven, she developed a progressive gait disorder with increased muscle tone in her lower limbs, bilateral ankle clonus and dysdiadochokinesis. She had frequent falls and deteriorating school performance. Despite physiotherapy, her spastic paraplegia was progressive. Whole exome sequencing (WES) identified a homozygous NM_024306.5:c.460C>T missense variant in the FA2H gene, of which her parents were heterozygous carriers. A brain MRI showed a slight reduction in the cerebellar volume with no iron deposits.
Conclusions
Pathogenic variants of the FA2H gene have been linked to neurodegeneration with iron accumulation in the brain, leukodystrophy and SPG35. When patients developed progressive gait deterioration since early childhood even if not exhibited hypointensity in the basal ganglia detected by neuroimaging, FA2H - related neurodegeneration with brain iron accumulation should be ruled out. FA2H/SPG35 disease is characterised by notable clinical and imaging variability, as well as phenotypic diversity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Pediatric Neurology, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Türkiye.
ORCID-Profile: Ayşenur Engin Erdal, Oya Kıreker Köylü, Ahmet Cevdet Ceylan, Ayşegül Neşe Çıtak Kurt
Zitieren
APA
Engin Erdal, A., Yürek, B., Kıreker Köylü, O., Ceylan, A. C., Çıtak Kurt, A. N., & Kasapkara, Ç. S. (2024). Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2023-0481
Vancouver
Engin Erdal A, Yürek B, Kıreker Köylü O, Ceylan AC, Çıtak Kurt AN, Kasapkara ÇS. Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration. Journal of Pediatric Endocrinology and Metabolism. 2024. doi:10.1515/jpem-2023-0481
BibTeX
@article{EnginErdal2024,
author = {Engin Erdal, Ayşenur and Yürek, Burak and Kıreker Köylü, Oya and Ceylan, Ahmet Cevdet and Çıtak Kurt, Ayşegül Neşe and Kasapkara, Çiğdem Seher},
title = {Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2024},
doi = {10.1515/jpem-2023-0481}
}
EUVIMED